Particle Therapy 2017
How important is mid-to-low dose? 1. Reduction of secondary tumour risk
Chung et al. IJROBP. 2013 Sep 1;87(1):46-52.)
Made with FlippingBook Online document
How important is mid-to-low dose? 1. Reduction of secondary tumour risk
Chung et al. IJROBP. 2013 Sep 1;87(1):46-52.)
Made with FlippingBook Online document